Abstract:
Introduction
Pharmaceuticals have been detected in trace concentrations in the natural aquatic environment at concentrations of ng L -1 to µg L -1 [1] [2] [3] [4] [5] [6] ; and this has been a global phenomenon [7] [8] [9] [10] . The presence of these compounds occur in sites as diverse as surface water [11] [12] [13] [14] , drinking water [15] [16] [17] [18] and sewage influent and effluent from water treatment plants [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] . Pharmaceuticals persist in the environment due to their inability to be degraded by natural physical processes such as sunlight photolysis or microbial processes [35] . Many compounds that have been detected, such as paracetamol, carbamazepine, diclofenac, and ibuprofen, are entirely synthetic and classed as xenobiotics [34] . As a result, pharmaceuticals detected in natural waters systems must have arisen from their medicinal usage prior to their appearance in urine or faeces. More worrying, their appearance may also be due to unused medications which have been disposed of improperly down the toilet, via the sewage system [36] or dumped into rubbish as landfill waste, leading to excessive discharge of leachate into environmental waters [37] .
The observed discharge of pharmaceuticals into the environment from sewage treatment plants suggests many conventional treatment processes are often not effective in reducing their levels in the wastewater stream. For instance, it has been reported that carbamazepine is poorly removed in the wastewater stream by primary sedimentation and secondary microbial degradation treatment processes [38] . Furthermore, the removal efficiencies of a pharmaceutical at a particular Central European Journal of Chemistry sewage treatment facility may vary depending on the sedimentation tank retention time, and the use of activated sludge treatment or membrane biofilters [39] [40] [41] [42] .
To improve the removal efficiencies, novel methods of treating pharmaceutically-rich sewage influent have been developed. Such treatment methods include advanced oxidation processes (AOPs) [43] involving ultraviolet (UV) irradiation alone [44, 45] , combining UV irradiation with hydrogen peroxide to generate hydroxyl (HO . ) radicals as an effective oxidising agent [46] [47] [48] [49] and incorporating hydrogen peroxide with Fe 2+ ions (photo-Fenton) which increases the efficiency of HO . radical generation [50] [51] [52] [53] [54] . More recently, heterogenous photocatalysts such as suspended titanium dioxide (TiO 2 ) have been used to generate HO . radicals [55] . The success of TiO 2 as a photocatalyst is dependent on its physicochemical properties as a semiconductor [56] .
Although the two most common forms of crystalline TiO 2 , anatase and rutile, show similar band gap energies, it has been reported that the photocatalytic activity of anatase is greater than that of rutile due to differences in the band gap position in these two polymorphs [57, 58] ; and thus TiO 2 photocatalysts generally have a high proportion of anatase. Many studies on the TiO 2 photocatalysed conversion of pesticides, dyes and synthetic compounds [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] have used photocatalysts with a high anatase content (such as Aeroxide P25, which is also known as Aeroxide P25 and typically consists of a 80:20 or 75:25 ratio of anatase:rutile, or pure anatase photocatalysts such as Hombikat UV100). Most of these studies have shown that the use of TiO 2 photocatalysts for the production of hydroxyl radicals from UV irradiation significantly increased degradation rate constants relative to homogenous direct UV photolysis. And compared with other homogenous AOPs, such as UV/H 2 O 2 /Fe 2+ (photo-Fenton), the photocatalyst can be easily separated from the reaction solution and recycled without the addition of extra reagents such as H 2 O 2 or iron salts [69] . Thus from the current literature, the use of TiO 2 as a photocatalyst may be an industrially-feasible tertiary sewage treatment process for the degradation of pharmaceuticals in wastewater.
Therefore, the aim of this review is to survey the extent of the use of TiO 2 mediated photocatalysis for the photodegradation of pharmaceuticals in aqueous solution. The removal efficiency obtained from various experimental parameters and the safety of TiO 2 photocatalysis as observed from current ecotoxicity data on different classes of pharmaceuticals and their photoproducts will be reported. In addition, the feasibility of using TiO 2 -assisted photodegradation processes in wastewater treatment of pharmaceuticals will also be evaluated.
Results and discussion

2.1.
Many of the studies reported an inverse relationship between the rate of TiO 2 -assisted photodegradation and the concentration of the substrate pharmaceutical due to the saturation of active sites on the TiO 2 surface [70] [71] [72] [73] [74] [75] . Furthermore, since pharmaceuticals or photoproducts produced from TiO 2 photocatalysis may themselves absorb UV radiation, their presence decreases the amount of incident radiation available to create valence hole-conduction band electron pairs in the TiO 2 material which mediates photocatalysis [70, 76] . For example, the apparent UV-A assisted TiO 2 -photocatalytic degradation rate constant for a 5 mg L -1 aqueous solution of diclofenac in deionized water was 0.1 min -1 but was decreased to an initial rate of 0.03 min
for a 20 mg L -1 diclofenac solution [70] . Moreover, 85% of a 5 mg L -1 aqueous atenolol solution in Milli-Q water was photoconverted during 240 minutes irradiation with Aeroxide P25 TiO 2 and UV-A; however only 54% of a 20 mg L -1 solution was degraded under the same conditions [71] . Similar decreases in photocatalytic degradation rates (from 0.0195 min -1 to 0.0037 min -1 ) were observed with 2 -10 mmol L -1 aqueous paracetamol solutions with UV-C irradiation and oxygen saturation in Milli-Q water at 26°C [77] . In addition, a decrease in the pseudo-first order degradation constant (from 0.229 min -1 to 0.078 min -1 ) for the UV-A/TiO 2 photocatalytic treatment of propanolol in Milli-Q water (pH = 7.0) was observed when a 200 µM solution of propanolol was irradiated as opposed to a 50 µM solution.
The amount of TiO 2 used may also significantly affect the degradation rate. The apparent first-order rate constant for amoxicillin degradation (10 mg L -1 ) increased from 0.0172 min -1 to 0.0237 min -1 when the suspended TiO 2 catalyst concentration was increased from 0.2 g L -1 to 0.8 g L -1 [78] , and this was accompanied by an increase in mineralization kinetics measured by total organic carbon experiments (0.0182 min -1 to 0.0235 min -1 for 0.2 g L -1 and 0.8 g L -1 TiO 2 loadings respectively). This phenomenon is predicted, because an increase in TiO 2 loading provides more binding sites for substrate molecules to adsorb to the TiO 2 surface [79] . However, an increase in TiO 2 loading from 0.2 to 0.8 g L -1 did not significantly increase the apparent Influence of pharmaceutical and TiO 2 concentration on photocatalytic degradation degradation rate contant (k app ) of carbamazepine (k app = 0.0311 min -1 and 0.037 min -1 respectively) [78] . Furthermore, no increase in the paracetamol degradation rate was observed with experiments using TiO 2 loadings > 0.8 g L -1 and the same initial pharmaceutical concentration [77] . With excessive TiO 2 loadings, It has been suggested that the TiO 2 particles in the centre of an irradiating vessel may be shielded from the incident UV by other TiO 2 particles, and thus particles in the centre do not contribute significantly to the production of (h + , e -) pairs [80] . As observed with the data collected in these previous studies, it is often not possible to predict the optimal loading of TiO 2 for the removal of a certain concentration of a particular pharmaceutical without the use of computer-aided modelling to determine optimal conditions for the photocatalytic reaction which one study has used and addressed [106] . Such modelling is necessary to determine the optimal quantity of TiO 2 needed for efficient photocatalysis in any particular sewage treatment facility, given that the expected concentration of a certain pharmaceutical in the wastewater is known.
Influence of pH on photocatalytic degradation
The pH of the solution can affect TiO 2 -assisted photodegradation rates. The surface of the photocatalyst may become positively or negatively charged depending on the ambient pH. TiO 2 has a point of zero charge at around pH = 6 [72]; thus, the surface of the photocatalyst will be positively charged in solutions below this pH and negatively charged above. Therefore, the pH will impact the adsorption of pharmaceuticals onto the TiO 2 surface depending on their chemical structure. [81] investigated the pH dependence of TiO 2 -assisted photodegradation of ciprofloxacin and found the photocatalytic process to be most efficient at pH = 9 (k = 0.38 min -1 ), whereas more extreme pH conditions significantly affected the degradation rates (k = 0.06 min -1 and 0.07 min -1 at pH = 3 and 11 respectively). This is due to the chemical structure of ciprofloxacin: at high pH, both the basic nitrogen on the piperazinyl moiety (pK a = 8.6) and the carboxyl group (pK a = 6.1) are deprotonated with the overall charge being negative. Therefore, the molecule is repelled by the negative surface charge of the TiO 2 and minimal adsorption occurs. Similarly, at low pH, both these functional groups are protonated, and hence, the overall positive charge of ciprofloxacin repels the postivelycharged surface of the photocatalyst. Similar variations in degradation rates have also been reported for other pharmaceuticals [82, 83] . However the acid-base properties of a pharmaceutical only partially account for the observed degradation rates. It has been proposed by Yang et al. 2010 [74] that the increased degradation rate observed with propanolol when treated with the UV-A/ TiO 2 system at pH = 5 relative to photodegradation at pH = 7 is because of the favourable adsorption of the electron-dense rings in propanolol onto the positivelycharged surface of the photocatalyst at this pH. This phenomenon, however, was not observed with other beta-blocker pharmaceuticals which lack the electronrich naphthyl rings, such as metoprolol and atenolol.
Given that the pH of wastewater is variable, it is again virtually impossible to evaluate the degradation of a particular pharmaceutical based solely on experiments carried out at one particular pH. Even if sewage water from one particular sewage facility is used as the matrix, it may not be representative of sewage water from another facility. Most sewage water is near neutral pH [84] , however, a pH = 8.2 has been reported for tertiary treated wastewater [96] . Therefore, to characterize more fully the degradation behaviour of a particular pharmaceutical by TiO 2 photocatalytic mechanisms, a detailed analysis of how pH changes affect photocatalysis is necessary.
Influence of experimental apparatus and matrix conditions on degradation rate
Photocatalytic rates for the degradation of pharmaceuticals may be dependent on the type of matrix and experimental apparatus used. For instance, the apparent degradation rate of carbamazepine was reduced from 0.28 min -1 to 0.16 min -1 in distilled water compared to bog lake water with 0.5 mg L -1 natural organic matter (NOM) [84] . The NOM not only acted as an inner filter which absorbed an estimated ~3.5% of the incident radiation, but effectively scavenged valence holes, and therefore, reduced the production of HO . radicals. Furthermore, the NOM used in this study had an overall negative charge and thus was attracted to the positively-charged surface of TiO 2 under the experimental pH range (5.0 -6.5). Similar results were reported in a recent study concerning the degradation of ranitidine in effluent water [85] . The pseudo-first order degradation constant of ranitidine in distilled water was over ten times greater than degradation in effluent water. In addition, only 8% of the degraded ranitidine achieved complete mineralization in an effluent water matrix after 55 min irradiation compared with 37% in distilled water after 73 min irradiation. Many studies have also involved photodegradation experiments in oxygensaturated or anoxic conditions [86] [87] [88] [89] 
Effect of TiO 2 type on photocatalytic degradation
The form of the TiO 2 used in experiments, such as whether the TiO 2 is in a suspension or immobilized form, or whether the TiO 2 has been doped, has a significant influence on photodegradation rates [91, 92] , and degradation efficiencies of these TiO 2 materials vary from one pharmaceutical to another. The photocatalytic activity of various forms of TiO 2 (pure anatase, pure rutile or an anatase-rutile mixture) have been compared in many studies [71, 75, 86, [93] [94] [95] [96] . As predicted by the band gap differences between anatase and rutile, higher conversion rates have been observed for anatasepredominant photocatalysts [71, 96] . For example, Silva and Faria (2008) [94] compared the photodegradation rates of clofibric acid using either commercial Aeroxide P25, anatase or rutile. The anatase photocatalyst degraded clofibric acid faster than the rutile potocatalyst but slower than Aeroxide P25 which has a mixed anatase:rutile composition. Another study confirmed that Aeroxide P25 is more photocatalytically efficient than pure form anatase or rutile photocatalysts probably as a result of reduced recombination of valence holeconduction band electron events on the surface or the bulk of the photocatalyst [97] . The use of various doped TiO 2 photocatalysts has been reported to remove potential organic contaminants such as phenol and azo dyes [98] . Little research has been done on the removal of pharmaceuticals with these doped TiO 2 photocatalysts, and while commerical preparations of doped materials are available in some countries for research (i.e., Japan) [100], much of the present literature focuses on the synthesis and While doping may be an effective strategy to decrease the band gap energy of TiO 2, and thus allow visible-light photocatalysis of organic contaminants, the decrease in the band gap energy may increase the ability for recombination [102] resulting in unpredictability of the photocatalytic efficiency of doped TiO 2 materials. Klauson et al. [91] observed that a 0.42% iron-doped TiO 2 material increased pharmaceutical photocatalysis by 10% compared to undoped TiO 2 ; however, when the dopant concentration in the TiO 2 was increased, the resultant material was less efficient in photocatalysis. Indeed, Choina et al. [103] observed that N, Fe or Zr doping of TiO 2 did not enhance the photodegradation of tetracyclines after 60 min degradation, compared to undoped Aeroxide P25 alone. While there is some evidence to suggest that doping of TiO 2 increases photocatalytic efficiency, many of these materials are not tandardized. Therefore, it is difficult to conclude whether they are truly more efficient than Aeroxide P25 or other standardized undoped materials. In addition, it would be useful to understand the photocatalytic abilities of one standardized doped TiO 2 material on a range of pharmaceutical compounds and compare its photocatalytic efficiency with undoped TiO 2 .
UV-C vs UV-A photodegradation of pharmaceuticals
The radiation source used to generate the (h + -e -) pairs in the TiO 2 photocatalysts may also affect photodegradation. Yang et al. (2009) [99] reported that TiO 2 -assisted paracetamol degradation rates using UV-C were significantly faster than UV-A. Furthermore, the photodegradation of tetracycline [101] was reportedly faster using UV-B (>254 nm) and Solarium lamps, in contrast to blacklight (365 nm) assisted photodegradation. In addition, the power of the lamps used for irradiation processes may significantly affect removal of pharmaceutical compounds as observed with the photocatalytic degradation of the antibacterial tetracycline [103] . While the ability to generate (h + -e -) pairs is independent of the wavelength of radiation used if the radiation is higher-energy than the TiO 2 band gap, other processes, such as direct photolysis, may further increase the apparent degradation rates observed as with the UV-C induced TiO 2 -assisted degradation of paracetamol [99] In contrast, no significant degradation was found for the drug when irradiated with UV-A alone, thus the observed degradation kinetics from the UV-A/TiO 2 process was solely derived from the TiO 2 photocatalysis of the pharmaceutical.
2.6.
The addition of electron acceptors to the photodegradation mixture significantly enhances photodegradation rates of substrates. As noted previously, oxygen saturation increases degradation rates. Paul et al. (2007) [95] observed a marked improvement in degradation of ciprofloxacin and other fluoroquinolones when bromate ion (BrO 3 -) was added as an electron acceptor. BrO 3 --promoted degradation when used in conjunction with visible light irradiation, whereas the absence of BrO 3 -or molecular oxygen (anoxic conditions) prevented any significant photodegradation. Since the band gap energy of TiO 2 [57] does not permit the formation of electron-hole pairs using visible light, the authors suggest that the photocatalytic oxidation of fluoroquinolones is mediated by the transfer of electron(s) to the electron acceptor resulting in the formation of unstable radical fluoroquinolone species which are further oxidized. Furthermore, the addition of hydroxyl radical scavengers (such as methanol) and superoxide scavengers (such as superoxide dismutase) decreased the degradation rate of ciprofloxacin under UV but not visible light irradiation. Such results suggested that the visible light-induced photocatalysis of ciprofloxacin is not mediated by electron-hole pairs as there are no significant changes to the photodegradation rate as a 
2.7.
The photodegradation pathways and extent of mineralization for TiO 2 -photocatalysed pharmaceuticals have been reported widely with some reports observing complete mineralization of pharmaceuticals [86, 103, 108] . Significant decreases in toxicity to the test organism has been observed for many studies after treatment with UV/TiO 2 [71, 87, 104] . Piecha et al. (2010) [87] observed that the photoproducts derived from UV/TiO 2 treatment of statin drugs were of significantly lower toxicity to Vibrio fischeri compared to the parent statins. In addition, the degradation of sulfa drugs was observed to produce a mixture of photoproducts with reduced toxicity [108] after 300 minutes irradiation.This is consistent with another study [109] which reported some toxicity even after treatment of sulfamethoxazole with UV/TiO 2 for 121 minutes. In contrast, UV/TiO 2 treatment of atenolol (TiO 2 loading = 150 mg L -1 ) in aqueous suspension for 15-30 minutes resulted in a significant reduction in toxicity to Daphnia magna [71] , and no antibacterial effects were observed after a 1 hr UV/TiO 2 treatment of an aqueous tetracycline suspension [101] .
Many studies have evaluated the ecotoxicity from the photoproducts of non-steroidal anti-inflammatory drug (NSAIDs) during the photocatalytic process, particularly diclofenac and ibuprofen [70, 73, 78, 102] . Previous experiments on the direct UV photolysis and the UV/H 2 O 2 and photoFenton mediated degradation of diclofenac has shown that identified photoirradiation intermediates, including 8-chlorocarbazoleacetic acid, were more toxic than diclofenac [110] , and indeed, some of these intermediates may also be formed by UV/TiO 2 systems. Calza et al. (2006) [106] observed that the toxicity of a 20-minute irradiated solution of diclofenac had a 72% growth inhibition of the luminescent bacterium Vibrio fischeri, whereas only 24% growth inhibition was observed with unirradiated suspensions. Several hydroxylated and chlorophenol derivatives, including 2,6-dichlorophenol and 4-chlorocatechol were identified in the study, along with the toxic compound hydroquinone. Rizzo et al. (2009) [78] reported that a 121-minute irradiation of diclofenac in aqueous solution lead to insignificant reductions in toxicity to Daphnia magna with a TiO 2 loading of 0.2 g L -1 . However, irradiated suspensions were less toxic than the unirradiated suspension when the TiO 2 concentration was increased to 0.4 g L -1 and 0.8 g L -1 . These results suggest that chloroderivative intermediates formed in the photodegradation pathway for diclofenac are clearly more toxic than diclofenac and an extended irradiation time (> 2 h) or an increase in TiO 2 concentration must be employed to ensure an efficient removal of diclofenac to form non-toxic and presumably mineralized products. Similar toxic intermediates were identified from the TiO 2 -assisted photodegradation of ibuprofen [73] . However, again it is important to note that sewage effluent and environmental concentrations of ibuprofen are likely to be much lower than those used in these experiments, and thus, the behaviour of the UV/TiO 2 photocatalytic system to such lowered concentrations may vary from these experimental results.
The production of intermediates which are more toxic than the parent pharmaceutical have also been reported for the TiO 2 -assisted degradation of amiloride [112] , the selective beta-2-adrenergic agonist salbutamol [107] , the antiepileptic agent carbamazepine [78, 93] and the antibacterial agent ofloxacin [71] . Unirradiated amiloride solutions were not shown to be toxic to Vibrio fischeri, but there was a 40% increase in toxicity to this organism after 4 h treatment with UV/TiO 2 . Identified photoproducts after prolonged photocatalysis included small molecules such as guanidine which was resistant to UV/TiO 2 treatment and not fully mineralized to nitrogenous by-products until > 45 h photocatalysis [112] . It is possible that the toxicity of the irradiated amiloride was attributed to the formation of smaller, unknown molecules. Similarly a solution of salbutamol [107] that had been irradiated in the presence of TiO 2 for 15 minute was observed to be more toxic than the unirradiated suspension, and a decrease in toxicity to Vibrio fischeri was only observed after irradiating the salbutamol suspension for 60 minutes. A potentially mutagenic and carcinogenic compound, acridine, was elucidated in the UV/TiO 2 treatment of carbamazepine [93] .
These findings clearly suggest that UV/TiO 2 processes successfully remove pharmaceuticals in aqueous suspension if an appropriate treatment timeframe is applied, and this parameter is especially important to consider when treating wastewater suspected of being rich in pharmaceuticals. The treatment timeframe should Degradation pathways for pharmaceuticals and ecotoxicity of photoproducts ideally be derived from bioassays which can provide information on whether certain timeframes are adequate to prevent the production of toxic intermediates and ensure the complete removal of toxic intermediates [113] .
3.
The literature suggests that TiO 2 -assisted degradation systems may be potentially feasible wastewater treatment processes for the degradation of pharamceuticals, given that some studies have reported on the complete mineralization of particular pharmaceuticals. However, several questions need to be answered before such technique can be employed successfully in any wastewater treatment facility:
-What pharmaceuticals are expected to appear in the influent of a wastewater treatment facility? This question can be answered at least in part from a knowledge of the particular medications used and disposed by a population served by the particular wastwater treatment plant. Such information can be obtained from studies which identify and quantify the type and amount of particular pharmaceuticals, or modelled from prescription data relating to the population served by a wastewater treatment facility.
-What pharmaceutical concentrations are expected? The removal of pharmaceuticals at higher concentrations may benefit from increased TiO 2 loadings (for example, in the range of 1-2 g L -1 ). -What potential effects does the wastewater matrix have on photocatalysis? As noted in this review, natural organic matter may act as inner filters or adsorb / trap radical species and inhibit TiO 2 photocatalysis mechanisms, thereby leading to decreased degradation of pharmaceuticals in the wastewater compared to solutions involving pure water which are the most likely situation in the laboratory.
-What are the operating conditions of the plant (pH, type and intensity of UV-irradiation available)? Such operating conditions may drastically affect the photocatalytic rates or types of photoproducts produced.
In addition, much of the current literature concerning the photocatalytic degradation of pharmaceuticals use undoped TiO 2 materials such as Aeroxide P25. While it has been observed that the use of doped TiO 2 materials has enhanced the photodegradation of various organic contaminants such as dyes and pesticides, little is known about the photocatalytic behaviour of these materials in the degradation of pharmaceutical compounds. Patents concerning the characterisation and synthesis of doped materials are abundantly available; however, the photoactivity of these novel materials on pharmaceutical compounds is poorly defined. Also, while there are standardized methods on the preparation of doped TiO 2 photocatalytic materials, commercially-prepared doped materials are less available as research reagents. Furthermore, while theoretically feasible, there are limitations to undoped TiO 2 which may render it impractical for sewage treatment after treatment times and loadings for the optimal removal of a particular pharmaceutical is considered. As the band gap of undoped TiO 2 requires UV to create valence hole-electron pairs, the cost of installing UV lamps and the energy required to run these lamps in some sewage treatment facilities may render the technique economically unfeasible. The use of TiO 2 at concentrations of 1-2 g L -1 to achieve optimal effects in the removal of a particular pharmaceutical may also be cost-inhibitive. Therefore, in order to establish effective strategies in the removal of pharmaceuticals from sewage water, further research comparing the photocatalytic abilities of both doped and undoped materials on the photodegradation of pharmaceutical compounds should be carried out. Because of the unpredictable efficiency of doped TiO 2 materials, such research is neccessary to determine whether these doped materials are truly more viable as photocatalysts than undoped TiO 2 for the photocatalytic degradation of pharmaceuticals. The use of inexpensive materials for the synthesis of doped TiO 2 photocatalysts would increase the sewage treatment feasibility of these materials. Once studies are completed on the ability of these doped TiO 2 photocatalysts to remove pharmaceutical compounds from water, it would be of benefit to commercialize an effective doped photocatalyst for sewage treatment use.
Conclusions
and future developments
